Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence.
about
SLC transporters as therapeutic targets: emerging opportunitiesA preliminary case study of androgen receptor gene polymorphism association with impulsivity in women with alcoholism.Benfotiamine attenuates inflammatory response in LPS stimulated BV-2 microglia.Change in psychiatric symptomatology after benfotiamine treatment in males is related to lifetime alcoholism severity.Multiplex Immunoassay of Plasma Cytokine Levels in Men with Alcoholism and the Relationship to Psychiatric Assessments.Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells.
P2860
Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Double-blind, randomized place ...... for severe alcohol dependence.
@en
Double-blind, randomized place ...... for severe alcohol dependence.
@nl
type
label
Double-blind, randomized place ...... for severe alcohol dependence.
@en
Double-blind, randomized place ...... for severe alcohol dependence.
@nl
prefLabel
Double-blind, randomized place ...... for severe alcohol dependence.
@en
Double-blind, randomized place ...... for severe alcohol dependence.
@nl
P2093
P2860
P1476
Double-blind, randomized place ...... for severe alcohol dependence
@en
P2093
Albert Poje
Elizabeth C Penick
Jan Campbell
Jianghua He
Merlin G Butler
P2860
P304
P356
10.1016/J.DRUGALCDEP.2013.07.035
P577
2013-08-11T00:00:00Z